Founded in 2005, InspireMD, Inc. (NSPR) is committed to developing advanced medical technologies designed to improve the lives of patients worldwide. Informally known as 'Inspire,' this Massachusetts-based medical device company excels in creating proprietary MicroNet™ stent platform technology for use in various vascular applications. Known for innovation, the company's landmark products, CGuard™ EPS and MGuard™ Prime, are explicitly engineered to address the unmet needs in the treatment of complex vascular diseases.
Notably, CGuard™ EPS is an embolic prevention stent system designed to prevent stroke caused by carotid artery disease. This device has an innovative design which incorporates a stent overlaid with a MicroNet™ mesh. The unique meshwork reduces stroke risk by preventing plaque detachment during or after the procedure. Meanwhile, MGuard™ Prime is a coronary stent system designed to reduce the risk of blood clot formation and subsequent heart attacks.
InspireMD's development and product line are grounded in the rigorous science and clinical research. These products have been proven effective in various clinical studies, earning the CE mark in Europe and recognition from the medical community. However, these procedures are still pending approval by the U.S. Food and Drug Administration.
The company's ticker symbol is NSPR, and it trades on the New York Stock Exchange. Despite various challenges over the years, including looming regulatory hurdles and market competition, InspireMD continues to push for innovation. The company is ever-focused on addressing the significant, unserved need in the cardiovascular market. Maintaining patient-safety as priority, it continues to strive to devise effective solutions for vascular complications.
InspireMD boasts an experienced leadership team that continually drives the company toward growth and success. The company's dedication to alleviating the burden of vascular diseases through quality, innovative medical technologies has cemented its reputation as a leading player in the medical device industry. Despite only being in operation for just over a decade and half, InspireMD's commitment to improving patient outcomes is evident, making them a significant entity in the health care technology field.